🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
59,53 USD
Máx. histórico
2.925,00
12010 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,96%
Rango 52 semanas
37,06 – 95,49
Variación hoy
-0,07%
Cierre anterior
59,57
Rango de hoy
59,25 – 60,89
Volumen hoy
1.327.132
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,88%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 20 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/11/2022 | 30,55 | 30,70 | 29,57 | 29,84 | -2,86% | 3,70% | 601.200 |
| 18/11/2022 | 31,26 | 31,26 | 30,54 | 30,72 | +0,49% | 2,30% | 574.700 |
| 17/11/2022 | 31,05 | 31,34 | 30,14 | 30,57 | -3,47% | 3,86% | 728.400 |
| 16/11/2022 | 33,60 | 33,76 | 31,36 | 31,67 | -5,91% | 7,16% | 896.200 |
| 15/11/2022 | 34,37 | 34,77 | 32,95 | 33,66 | +1,78% | 5,30% | 962.500 |
| 14/11/2022 | 34,30 | 34,62 | 33,01 | 33,07 | -4,12% | 4,69% | 861.500 |
| 11/11/2022 | 34,75 | 35,50 | 33,64 | 34,49 | -0,69% | 5,34% | 1.138.200 |
| 10/11/2022 | 32,30 | 35,11 | 32,00 | 34,73 | +14,02% | 9,63% | 1.553.400 |
| 09/11/2022 | 33,10 | 33,39 | 29,43 | 30,46 | -8,53% | 11,96% | 1.607.400 |
| 08/11/2022 | 34,65 | 35,71 | 32,94 | 33,30 | -2,94% | 7,99% | 2.012.900 |
| 07/11/2022 | 34,27 | 35,71 | 34,22 | 34,31 | +1,03% | 4,35% | 987.600 |
| 04/11/2022 | 34,46 | 35,57 | 33,29 | 33,96 | -0,59% | 6,60% | 848.600 |
| 03/11/2022 | 34,05 | 35,15 | 33,63 | 34,16 | -1,30% | 4,46% | 456.400 |
| 02/11/2022 | 35,45 | 37,07 | 34,56 | 34,61 | -2,56% | 7,08% | 848.000 |
| 01/11/2022 | 35,58 | 36,19 | 35,08 | 35,52 | +2,04% | 3,12% | 520.900 |
| 31/10/2022 | 35,38 | 35,51 | 34,21 | 34,81 | -2,96% | 3,66% | 726.700 |
| 28/10/2022 | 33,33 | 35,95 | 33,03 | 35,87 | +8,07% | 8,76% | 717.500 |
| 27/10/2022 | 33,00 | 33,77 | 32,65 | 33,19 | +1,31% | 3,39% | 685.800 |
| 26/10/2022 | 32,52 | 33,70 | 32,18 | 32,76 | +0,61% | 4,67% | 580.800 |
| 25/10/2022 | 31,49 | 32,90 | 31,49 | 32,56 | +3,96% | 4,46% | 649.100 |
| 24/10/2022 | 33,29 | 33,53 | 30,12 | 31,32 | -6,20% | 10,24% | 789.200 |
| 21/10/2022 | 32,64 | 33,51 | 31,86 | 33,39 | +2,39% | 5,07% | 599.200 |
| 20/10/2022 | 32,28 | 33,43 | 32,21 | 32,61 | +0,71% | 3,78% | 605.500 |
| 19/10/2022 | 34,40 | 34,58 | 31,88 | 32,38 | -7,72% | 7,85% | 1.000.100 |
| 18/10/2022 | 34,79 | 35,09 | 33,51 | 35,09 | +3,24% | 4,54% | 775.300 |
| 17/10/2022 | 32,74 | 34,26 | 32,60 | 33,99 | +6,15% | 5,07% | 802.500 |
| 14/10/2022 | 32,78 | 33,07 | 31,83 | 32,02 | -0,93% | 3,78% | 585.400 |
| 13/10/2022 | 30,75 | 32,73 | 30,39 | 32,32 | +1,00% | 7,61% | 746.800 |
| 12/10/2022 | 31,42 | 32,07 | 30,75 | 32,00 | +2,40% | 4,20% | 622.400 |
| 11/10/2022 | 30,54 | 31,98 | 30,02 | 31,25 | +2,49% | 6,42% | 719.400 |